Ahmed Abomhya, MD

@Samah_Zinhom ❤️🤍❤️

العيد فرحته بوجودنا جمب احبابنا العيد عيدين بزوجي ومريومتي 🫂💙💙 الله يحفظهم ليا 🎉🎊

@Mohamdelbe3lawy مبارك يا ابو مالك والله فرحتلك كتير بالتوفيق يارب

اللهم لك الحمد ♥️♥️ Matched, no more words 😌 #match2026

I’m presenting at #DDW2026! Join me to learn, connect, and move the field forward together. Register today at app.ingo.me/q/w3x5r .

@MondayNightIBD @ebmedgi @AGA_CGH @DCharabaty @AmCollegeGastro @CrohnsColitisFn @IBDProNews @CrohnsColitisUK @JCC_IBD

@MondayNightIBD @ebmedgi @AGA_CGH @DCharabaty @AmCollegeGastro @CrohnsColitisFn @IBDProNews @CrohnsColitisUK @JCC_IBD

#IBDAlgorithm @MondayNightIBD @EBMedGI #CGH4ALL @AGA_CGH @Dcharabaty @AmCollegeGastro @CrohnsColitisFn @IBDProNews @CrohnsColitisUK @JCC_IBD

@john_damianosMD I believe studies of this kind should move beyond reporting a plausible association and explore potential areas where stewardship-based measures could be implemented. It is unclear how the observed association alone can inform future clinical practice.

@john_damianosMD Randomized controlled trials are not feasible in this context, yet observational studies have major limitations when used to assess associations related to pharmacotherapies.

⚠️Childhood antibiotic use is a risk factor for developing inflammatory bowel disease, with about 42% higher risk. The risk for ulcerative colitis was 23% and for Crohn disease was 59%. This was true despite controlling for infections. academic.oup.com/ibdjournal/adv…

The Montreal Classification for Crohn’s disease 📍

@AhmedMAmer12 @AliMHammadMD الف سلامه يا دكتره There is no evidence that I came across that suggests a strong association between Caffeine tabs and PUD. Unless those tablets had NSAIDs along with the caffeine!

@AliMHammadMD أنا كنت زي الفل برضه حتى هذه الطامة 😂 روحت الطوارئ بهيموجلوبين ٤.٨ 😂 انا حاليا أيام الشغل في رمضان بشرب كوباية قهوة قبل الفجر. و ال weekends مابشربش خالص

*دي مش نصيحة طبية!* لمدمنين القهوة و كل أنواع الكافيين أنصحكم بكبسولات الكافيين ممتدة المفعول بتتجاب من على أمازون عادي أنا جربت اخد كبسوله ١٠٠ ملج على السحور و مفعولها سحري في منع الصداع و الخمول اللي كان بيبقى في اول كام يوم رمضان الصبح.

@mfalmeqdadi @garvs_72 @ElsayesKhaled PDs think about “who is going to rank them” when they are sending interviews invites. This is how a PD ensures they will fill their spots. When it comes to ROL, they should rank based on who they think are the strongest and best fit.

@Abdelsatar78 @garvs_72 @ElsayesKhaled Interesting. I doubt this is how it’s perceived amongst students. This is very idealistic. But you’re probably right. Thanks for this.

- Match Applicants; my young colleagues and dear mentees: The #match2027 season is back and I wish you the best. - During this critical time, I always receive a question regarding the letter of intent and I always advise honesty, just send this to your number #1 program in your rank list. - - - -Applicant are anxious; what if #1 program doesn’t rank me, will I unmatch? - I have always been uncomfortable with the idea of a "Letter of Intent" in the residency selection process. -Certain program directors require this letter to prioritize candidates. This practice can potentially encourage candidates to misrepresent themselves. -Unfortunately, some applicants dishonesty submit this letter of intent to multiple programs instead of focusing on their top choice. -Why not simply rank applicants based on their qualifications ? I hope to hear views of applicants and Program directors #residency #medstudent #IMG #meded #nrmp #MedTwitter #radresidents @theAPDIR #radres @theAPDR

@mfalmeqdadi @garvs_72 @ElsayesKhaled A letter of intent should express a candidate’s genuine interest in a specific program. For a PD, this interest might suggest that the candidate is more likely to thrive within the program’s environment and successfully navigate its unique challenges.

@Abdelsatar78 @garvs_72 @ElsayesKhaled Interesting. Today I learned. Perhaps I’m the only one who perceived it this way. Doesn’t explain then why a letter of intent is needed then

@garvs_72 @mfalmeqdadi @ElsayesKhaled This is exactly how it works! I am surprised how anyone who went through the NRMP MATCH doesn’t know that! I hope no PD out there does their ROL based on “who is going to rank them”!

This is not correct. The mechanics of the match are such that failing to match a higher-ranked applicant or program does not affect the chance of matching lower-ranked ones. The actual internal order of the ROL does not affect the chance of a program getting filled or an applicant finding a match The program and applicant-proposing versions of the match are essentially identical with no difference in the number of programs with unfilled positions Programs that manipulate their ROLs in this way are not increasing their chance of filling, they are just decreasing their probability of matching highly competitive/desirable applicants cc: @jbcarmody

@mfalmeqdadi @ElsayesKhaled This is not how the algorithm works. Both parties can rank based on their preferences and this should not affect if they are going to match or not.

Because the programs rank based on who’s going to rank them (the algorithm is rigged towards the applicants). Thus, ranking top qualified alllicants who aren’t interested in ranking your program high, you risk going unmatched and missing on those who wanted your program but others ranked them higher than you. It’s tricky.

@IBD_FloMD reporting on STENOVA Trial: A Phase 2a, RCT, Double-blind Study of Ontunisertib (AGMB-129) in Fibrostenosing Crohn's Disease - note inclusion criteria for first study in Stricture - unique patient characteristic compared to typical anti inflammatory (longer duration on disease, more male, etc) - no cardiac/cancer safety signal , exhibiting gut specific effect - initial positive signal for anti-fibrosis effects on imaging and endoscopy, while minimal symptoms at baseline remain unchanged

@Alomari_MD @Shrouq_ms @DrAhmedSalem2 @LinaAlQirem @AdalGuzmanMD @EffaZahid @Eldesouki_mo @JHashashMD @AsadurRahman87 @uams_GIHep @HazemAbosheaish Congrats

Immensely proud of our amazing team! An outstanding #DDWMeeting with 30+ accepted abstracts and 8 oral presentations. Thank you to our collaborators and colleagues—this success is truly a team effort. @Shrouq_ms @DrAhmedSalem2 @LinaAlQirem @AdalGuzmanMD @EffaZahid @Eldesouki_mo

@AmCollegeGastro (3) ULTRA 2 reported: • Week 8: 9.2% vs 6.9% (P = 0.559) • Week 52: 10.2% vs 3% (P = .039) (Sandborn et al., Gastroenterology 2012) This is clinically relevant, as patients demonstrating response at week 8 may still achieve remission at week 52 with continued treatment.

The 2025 @AmCollegeGastro ulcerative colitis guideline appears to misstate ULTRA 2 remission data. 🧵(1)

@AmCollegeGastro (2)The guideline states “However, at week 52, although patients previously exposed to anti-TNF agents receiving adalimumab achieved remission at week 8 more often than those who received placebo (9.2% vs 6.9%, P = 0.559), the rate was not significantly different.”@AmCollegeGastro